Dow+89.64up+0.79%
11,502.51
Nasdaqunch0.00%
2,382.46
S&Punch0.00%
1,281.66
Stock strategy © Getty Images

The Amateur / Vad Yazvinski

Portfolio

SymbolNameQuantity*Last PriceToday's $ ChangeToday's % ChangeOverall $ GainOverall % GainMarket Value
IDIXIdenix Pharmaceuticals Inc595.000$8.23$0.000.00%-$235.14-4.58%$4,896.85
MITIMicromet Inc1,080.000$6.22$0.000.00%$2,444.8057.25%$6,715.01
AMGNAmgen Inc80.000$63.71$0.000.00%$28.200.56%$5,096.80
NPSPNPS Pharmaceuticals Inc915.000$7.94$0.000.00%$2,217.5943.93%$7,265.10
AHSAMN Healthcare Services Inc260.000$18.82$0.000.00%-$69.60-1.40%$4,893.20
CGRBCougar Biotechnology Inc145.000$34.64$0.000.00%-$55.59-1.09%$5,022.80
APEIAmerican Public Education Inc110.000$43.20$0.000.00%-$420.90-8.14%$4,752.00
SUPXSupertex Inc165.000$29.98$0.000.00%$26.250.53%$4,946.70
NUVANuVasive Inc90.000$50.84$0.000.00%-$393.00-7.91%$4,575.60
MXWLMaxwell Technologies Inc350.000$12.68$0.000.00%-$302.01-6.37%$4,438.00
FORRForrester Research Inc150.000$34.29$0.000.00%$199.504.04%$5,143.50
GKKGramercy Capital Corp-740.000$6.44$0.000.00%$147.783.01%-$4,765.60
AUOAU Optronics Depository Receipt-380.000$11.84$0.000.00%-$98.61-2.24%-$4,499.20
LPLLG Display ADR each representing 1/2 Ord Shs-335.000$12.75$0.000.00%$534.3911.12%-$4,271.25
TAT&T Inc-160.000$31.20$0.000.00%-$131.81-2.71%-$4,992.00
AFAMAlmost Family Inc110.000$43.79$0.000.00%$551.5012.93%$4,816.90
CIENCiena Corp-270.000$17.40$0.000.00%$365.697.22%-$4,698.00
CALMCal-Maine Foods Inc100.000$40.28$0.000.00%-$787.00-16.34%$4,028.00
 Cash      $56,794.10
 Totals  $0.00 $158.510.16%$100,158.51
Quotes delayed at least 20 minutes.
* A negative quantity value indicates that the contestant has taken a short position.

Fund data provided by Morningstar, Inc. © 2005. All rights reserved.
StockScouter data provided by Gradient Analytics, Inc.
Quotes supplied by Comstock, an Interactive Data company.
MSN Money's editorial goal is to provide a forum for personal finance and investment ideas. Our articles, columns, message board posts and other features should not be construed as investment advice, nor does their appearance imply an endorsement by Microsoft of any specific security or trading strategy. An investor's best course of action must be based on individual circumstances.